CIPLA LTD.
NSE : CIPLABSE : 500087ISIN
CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse
: Cipla
BSE885.20-17.8 (-1.97 % )
PREV CLOSE (Rs.) 903.00
OPEN PRICE (Rs.) 928.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 645614
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE885.20 -17.2 (-1.91 % )
PREV CLOSE(Rs.) 902.40
OPEN PRICE (Rs.) 921.95
BID PRICE (QTY) 885.20 (5375 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 11667200
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Financial ratio
Particulars | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 19.18 | 18.96 | 17.52 | 12.51 | 16.93 |
CEPS(Rs) | 32.83 | 32.35 | 29.43 | 29.40 | 26.76 |
DPS(Rs) | 4.00 | 3.00 | 3.00 | 2.00 | 2.00 |
Book NAV/Share(Rs) | 194.85 | 185.62 | 175.92 | 155.15 | 142.23 |
Tax Rate(%) | 28.98 | 27.39 | 14.98 | 14.71 | 19.20 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 11.45 | 12.00 | 16.12 | 16.92 | 17.98 |
EBIT Margin(%) | 8.76 | 9.40 | 11.72 | 9.44 | 14.02 |
Pre Tax Margin(%) | 8.03 | 8.70 | 10.97 | 8.35 | 12.52 |
PAT Margin (%) | 5.70 | 6.31 | 9.33 | 7.13 | 10.12 |
Cash Profit Margin (%) | 9.76 | 10.90 | 15.57 | 16.17 | 15.59 |
Performance Ratios | |||||
ROA(%) | 6.56 | 6.50 | 6.52 | 4.97 | 7.28 |
ROE(%) | 10.09 | 10.37 | 10.65 | 8.72 | 12.61 |
ROCE(%) | 12.53 | 11.94 | 10.20 | 8.28 | 13.24 |
Asset Turnover(x) | 1.15 | 1.03 | 0.70 | 0.70 | 0.72 |
Sales/Fixed Asset(x) | 1.88 | 1.79 | 1.25 | 1.36 | 1.40 |
Working Capital/Sales(x) | 3.71 | 2.76 | 2.18 | 2.70 | 12.95 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.53 | 0.56 | 0.80 | 0.74 | 0.72 |
Receivable days | 54.10 | 55.36 | 68.17 | 61.60 | 57.62 |
Inventory Days | 56.12 | 61.13 | 90.71 | 91.41 | 100.43 |
Payable days | 57.55 | 59.02 | 57.37 | 46.96 | 48.81 |
Valuation Parameters | |||||
PER(x) | 22.05 | 27.91 | 31.01 | 47.35 | 30.26 |
PCE(x) | 12.88 | 16.36 | 18.46 | 20.15 | 19.14 |
Price/Book(x) | 2.17 | 2.85 | 3.09 | 3.82 | 3.60 |
Yield(%) | 0.95 | 0.57 | 0.55 | 0.34 | 0.39 |
EV/Net Sales(x) | 2.10 | 2.83 | 3.09 | 3.55 | 3.35 |
EV/Core EBITDA(x) | 10.33 | 13.86 | 16.67 | 18.90 | 16.92 |
EV/EBIT(x) | 15.12 | 20.62 | 26.28 | 37.01 | 23.52 |
EV/CE(x) | 1.53 | 1.95 | 2.07 | 2.45 | 2.16 |
M Cap / Sales | 1.99 | 2.61 | 2.89 | 3.31 | 3.03 |
Growth Ratio | |||||
Net Sales Growth(%) | 4.70 | 7.96 | 5.29 | 5.88 | 19.83 |
Core EBITDA Growth(%) | 3.91 | 18.99 | 3.94 | 0.62 | 15.50 |
EBIT Growth(%) | 5.69 | 26.01 | 29.11 | -28.55 | 6.10 |
PAT Growth(%) | 2.48 | 6.36 | 36.16 | -25.30 | 11.26 |
EPS Growth(%) | 1.16 | 8.23 | 40.05 | -26.10 | 15.11 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | 0.18 | 0.29 | 0.29 | 0.33 | 0.46 |
Current Ratio(x) | 2.66 | 3.29 | 2.82 | 2.60 | 1.14 |
Quick Ratio(x) | 1.67 | 2.24 | 1.77 | 1.56 | 0.65 |
Interest Cover(x) | 12.04 | 13.34 | 15.61 | 8.67 | 9.36 |
Total Debt/Mcap(x) | 0.08 | 0.10 | 0.09 | 0.09 | 0.13 |